Dr Antony Cooper

Back to

Associate Professor Antony Cooper is Head of both the Neurodegeneration & Neurogenomics Program and Neuroscience Division at the Garvan Institute of Medical Research.

Research Interests

Our main focus is to identify the underlying disease mechanism(s) of Parkinson’s Disease so as to identify and develop Neuroprotective therapies, especially those to slow/stop disease progression. Intensive Neurogenomic approaches are also being employed to identify peripheral biomarkers for both presymptomatic diagnosis and efficacy assessment of new disease-modifying therapies. Whole Genome Sequencing and transcriptional analysis of Bipolar Disorder pedigrees are being conducted to provide insights into the basis of this disease.

Phone

9295 8238

Book Chapters | 2022

Wyse RK; Cooper AA; Stott SRW, 2022, 'Chapter 3: The Role of Clinical Medicine', in Drug Repurposing, pp. 24 - 51, http://dx.doi.org/10.1039/9781839163401-00024
Journal articles | 2024

Farrow SL; Gokuladhas S; Schierding W; Pudjihartono M; Perry JK; Cooper AA; O’Sullivan JM, 2024, 'Identification of 27 allele-specific regulatory variants in Parkinson’s disease using a massively parallel reporter assay', npj Parkinson's Disease, 10, http://dx.doi.org/10.1038/s41531-024-00659-5

Journal articles | 2024

Gokuladhas S; Fadason T; Farrow S; Cooper A; O’Sullivan JM, 2024, 'Discovering genetic mechanisms underlying the co-occurrence of Parkinson’s disease and non-motor traits', npj Parkinson's Disease, 10, http://dx.doi.org/10.1038/s41531-024-00638-w

Journal articles | 2023

Guennewig B; Lim J; Marshall L; McCorkindale AN; Paasila PJ; Patrick E; Kril JJ; Halliday GM; Cooper AA; Sutherland GT, 2023, 'Author Correction: Defining early changes in Alzheimer’s disease from RNA sequencing of brain regions differentially affected by pathology (Scientific Reports, (2021), 11, 1, (4865), 10.1038/s41598-021-83872-z)', Scientific Reports, 13, http://dx.doi.org/10.1038/s41598-023-36807-9

Journal articles | 2023

Martínez-Jiménez M; Ortiz IG; Kavanagh T; Marshall L; Heath A; Mitchell PB; Schofield PR; Cooper AA; Fullerton J; Toma C, 2023, 'F37. STUDY OF ALTERNATIVE SPLICING EVENTS IN MULTIPLEX BIPOLAR FAMILIES', European Neuropsychopharmacology, 75, pp. S240 - S240, http://dx.doi.org/10.1016/j.euroneuro.2023.08.425

Journal articles | 2023

Ortiz IG; Jiménez MM; Kavanagh T; Marshall L; Heath A; Lozano JJL; Schoefield PR; Mitchell PB; Cooper AA; Fullerton J; Toma C, 2023, 'F45. RNA SEQUENCING ANALYSES IN BIPOLAR MULTIPLEX FAMILIES POINT TO NOVEL GENES AND DYSREGULATED PATHWAYS', European Neuropsychopharmacology, 75, pp. S245 - S245, http://dx.doi.org/10.1016/j.euroneuro.2023.08.433

Journal articles | 2023

Youssef P; Hughes L; Kim WS; Halliday GM; Lewis SJG; Cooper A; Dzamko N, 2023, 'Evaluation of plasma levels of NFL, GFAP, UCHL1 and tau as Parkinson's disease biomarkers using multiplexed single molecule counting', Scientific Reports, 13, http://dx.doi.org/10.1038/s41598-023-32480-0

Journal articles | 2022

Bournazos AM; Riley LG; Bommireddipalli S; Ades L; Akesson LS; Al-Shinnag M; Alexander SI; Archibald AD; Balasubramaniam S; Berman Y; Beshay V; Boggs K; Bojadzieva J; Brown NJ; Bryen SJ; Buckley MF; Chong B; Davis MR; Dawes R; Delatycki M; Donaldson L; Downie L; Edwards C; Edwards M; Engel A; Ewans LJ; Faiz F; Fennell A; Field M; Freckmann ML; Gallacher L; Gear R; Goel H; Goh S; Goodwin L; Hanna B; Harraway J; Higgins M; Ho G; Hopper BK; Horton AE; Hunter MF; Huq AJ; Josephi-Taylor S; Joshi H; Kirk E; Krzesinski E; Kumar KR; Lemckert F; Leventer RJ; Lindsey-Temple SE; Lunke S; Ma A; Macaskill S; Mallawaarachchi A; Marty M; Marum JE; McCarthy HJ; Menezes MP; McLean A; Milnes D; Mohammad S; Mowat D; Niaz A; Palmer EE; Patel C; Patel SG; Phelan D; Pinner JR; Rajagopalan S; Regan M; Rodgers J; Rodrigues M; Roxburgh RH; Sachdev R; Roscioli T; Samarasekera R; Sandaradura SA; Savva E; Schindler T; Shah M; Sinnerbrink IB; Smith JM; Smith RJ; Springer A; Stark Z; Strom SP; Sue CM; Tan K; Tan TY; Tantsis E; Tchan MC; Thompson BA; Trainer AH; van Spaendonck-Zwarts K; Walsh R; Warwick L; White S; White SM; Williams MG, 2022, 'Standardized practices for RNA diagnostics using clinically accessible specimens reclassifies 75% of putative splicing variants', Genetics in Medicine, 24, pp. 130 - 145, http://dx.doi.org/10.1016/j.gim.2021.09.001

Journal articles | 2022

Farrow SL; Cooper AA; O’Sullivan JM, 2022, 'Redefining the hypotheses driving Parkinson’s diseases research', npj Parkinson's Disease, 8, http://dx.doi.org/10.1038/s41531-022-00307-w

Journal articles | 2022

Farrow SL; Schierding W; Gokuladhas S; Golovina E; Fadason T; Cooper AA; O'Sullivan JM, 2022, 'Establishing gene regulatory networks from Parkinson's disease risk loci', Brain, 145, pp. 2422 - 2435, http://dx.doi.org/10.1093/brain/awac022

Journal articles | 2022

Ho D; Schierding W; Farrow SL; Cooper AA; Kempa-Liehr AW; O’Sullivan JM, 2022, 'Machine Learning Identifies Six Genetic Variants and Alterations in the Heart Atrial Appendage as Key Contributors to PD Risk Predictivity', Frontiers in Genetics, 12, http://dx.doi.org/10.3389/fgene.2021.785436

Journal articles | 2022

Huang Y; Wei J; Cooper A; Morris MJ, 2022, 'Parkinson's disease: From genetics to molecular dysfunction and targeted therapeutic approaches', Genes and Diseases, 10, pp. 786 - 798, http://dx.doi.org/10.1016/j.gendis.2021.12.015

Journal articles | 2022

Lau D; Magnan C; Hill K; Cooper A; Gambin Y; Sierecki E, 2022, 'Single Molecule Fingerprinting Reveals Different Amplification Properties of α-Synuclein Oligomers and Preformed Fibrils in Seeding Assay', ACS Chemical Neuroscience, 13, pp. 883 - 896, http://dx.doi.org/10.1021/acschemneuro.1c00553

Journal articles | 2022

Zhang JD; Le MN; Hill KJ; Cooper AA; Stuetz RM; Donald WA, 2022, 'Identifying robust and reliable volatile organic compounds in human sebum for biomarker discovery', Analytica Chimica Acta, 1233, http://dx.doi.org/10.1016/j.aca.2022.340506

Journal articles | 2021

Guennewig B; Lim J; Marshall L; McCorkindale AN; Paasila PJ; Patrick E; Kril JJ; Halliday GM; Cooper AA; Sutherland GT, 2021, 'Defining early changes in Alzheimer’s disease from RNA sequencing of brain regions differentially affected by pathology', Scientific Reports, 11, http://dx.doi.org/10.1038/s41598-021-83872-z

Journal articles | 2021

Guennewig B; Lim J; Marshall L; McCorkindale AN; Paasila PJ; Patrick E; Kril JJ; Halliday GM; Cooper AA; Sutherland GT, 2021, 'Author Correction: Defining early changes in Alzheimer’s disease from RNA sequencing of brain regions differentially affected by pathology (Scientific Reports, (2021), 11, 1, (4865), 10.1038/s41598-021-83872-z)', Scientific Reports, vol. 11, http://dx.doi.org/10.1038/s41598-021-97076-y

Journal articles | 2021

O'Sullivan JM; den Heijer JM; Groeneveld GJ; Cooper AA, 2021, 'Intronic Haplotypes in GBA Modify Age at Diagnosis of Parkinson's: Replication in a Subgroup', Movement Disorders, vol. 36, pp. 1468 - 1470, http://dx.doi.org/10.1002/mds.28620

Journal articles | 2020

Schierding W; Farrow S; Fadason T; Graham OEE; Pitcher TL; Qubisi S; Davidson AJ; Perry JK; Anderson TJ; Kennedy MA; Cooper A; O'Sullivan JM, 2020, 'Common Variants Coregulate Expression of GBA and Modifier Genes to Delay Parkinson's Disease Onset', Movement Disorders, 35, pp. 1346 - 1356, http://dx.doi.org/10.1002/mds.28144

Journal articles | 2020

Toma C; Shaw AD; Overs BJ; Mitchell PB; Schofield PR; Cooper AA; Fullerton JM, 2020, 'De Novo Gene Variants and Familial Bipolar Disorder', JAMA network open, vol. 3, pp. e203382, http://dx.doi.org/10.1001/jamanetworkopen.2020.3382

Journal articles | 2019

Montgomery MK; Osborne B; Brandon AE; O'Reilly L; Fiveash CE; Brown SHJ; Wilkins BP; Samsudeen A; Yu J; Devanapalli B; Hertzog A; Tolun AA; Kavanagh T; Cooper AA; Mitchell TW; Biden TJ; Smith NJ; Cooney GJ; Turner N, 2019, 'Regulation of mitochondrial metabolism in murine skeletal muscle by the medium-chain fatty acid receptor Gpr84', FASEB Journal, 33, pp. 12264 - 12276, http://dx.doi.org/10.1096/fj.201900234R

Journal articles | 2018

Dong X; Liao Z; Gritsch D; Hadzhiev Y; Bai Y; Locascio JJ; Guennewig B; Liu G; Blauwendraat C; Wang T; Adler CH; Hedreen JC; Faull RLM; Frosch MP; Nelson PT; Rizzu P; Cooper AA; Heutink P; Beach TG; Mattick JS; Müller F; Scherzer CR, 2018, 'Enhancers active in dopamine neurons are a primary link between genetic variation and neuropsychiatric disease', Nature Neuroscience, 21, pp. 1482 - 1492, http://dx.doi.org/10.1038/s41593-018-0223-0

Journal articles | 2015

Murphy KE; Gysbers AM; Abbott SK; Spiro AS; Furuta A; Cooper A; Garner B; Kabuta T; Halliday GM, 2015, 'Lysosomal-associated membrane protein 2 isoforms are differentially affected in early Parkinson's disease', Movement Disorders, 30, pp. 1639 - 1647, http://dx.doi.org/10.1002/mds.26141

Journal articles | 2014

Guennewig B; Cooper AA, 2014, 'The central role of noncoding RNA in the brain', , 116, pp. 153 - 194, http://dx.doi.org/10.1016/B978-0-12-801105-8.00007-2

Journal articles | 2014

Murphy KE; Cottle L; Gysbers AM; Cooper AA; Halliday GM, 2014, 'ATP13A2 (PARK9) protein levels are reduced in brain tissue of cases with Lewy bodies', Acta Neuropathologica Communications, 2, http://dx.doi.org/10.1186/2051-5960-1-11

Journal articles | 2014

Murphy KE; Gysbers AM; Abbott SK; Tayebi N; Kim WS; Sidransky E; Cooper A; Garner B; Halliday GM, 2014, 'Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's disease', Brain, 137, pp. 834 - 848, http://dx.doi.org/10.1093/brain/awt367

Journal articles | 2014

Kong SMY; Chan BKK; Park JS; Hill KJ; Aitken JB; Cottle L; Farghaian H; Cole AR; Lay PA; Sue CM; Cooper AA, 2014, 'Parkinson's disease-linked human PARK9/ATP13A2 maintains zinc homeostasis and promotes α-Synuclein externalization via exosomes', Human Molecular Genetics, vol. 23, pp. 2816 - 2833, http://dx.doi.org/10.1093/hmg/ddu099

Journal articles | 2012

Chesi A; Kilaru A; Fang X; Cooper A, 2012, 'The role of the Parkinson's disease gene PARK9 in essential cellular pathways and the manganese homeostasis network in yeast', PLoS One, 7, pp. e34178, http://dx.doi.org/10.1371/journal.pone.0034178

Journal articles | 2012

Protter D; Lang C; Cooper A; Lang C, 2012, 'alphaSynuclein and mitochondrial dysfunction: A pathogenic partnership in Parkinson's Disease?', Parkinson's Disease, 2012, pp. 829207, http://dx.doi.org/10.1155/2012/829207

Journal articles | 2011

Park JS; Mehta P; Cooper A; Veivers D; Heimbach A; Stiller B; Kubisch C; Fung VS; Krainc D; Mackay-Sim A; Sue CM, 2011, 'Pathogenic effects of novel mutations in the P-type ATPase ATP13A2 (PARK9) causing Kufor-Rakeb syndrome, a form of early-onset parkinsonism', Human Mutation, 32, pp. 956 - 964, http://dx.doi.org/10.1002/humu.21527

Journal articles | 2011

Webber K; Cooper A; Kleiven H; Yip D; Goldstein D, 2011, 'Management of metastatic renal cell carcinoma in the era of targeted therapies', Internal Medicine Journal, 41, pp. 594 - 605

Journal articles | 2010

McConoughey S; Basso SJ; Nietsetskaya Z; Sleiman SF; Smirnova T; Langley B; Mahishi L; Cooper AJ; Antonyak MA; Cerione RA; Li B; Starkov A; Chaturvedi R; Beale M; Coppola G; Geschwind D; Ryu H; Li XR; Iismaa SE; Pallos J; Pasternack R; Hils M; Fan J; Raymond LA; Marsh JL; Thompson LM; Ratan R, 2010, 'Inhibition of transglutaminase 2 mitigates transcriptional dysregulation in models of Huntington disease', EMBO Journal, 2, pp. 349 - 370

Journal articles | 2010

Su LJ; Auluck PK; Outeiro TF; Yeger-Lotem E; Kritzer J; Tardiff D; Strathearn K; Liu F; Cao S; Hamamichi S; Hill KJ; Caldwell K; Bell GW; Fraenkel E; Cooper A; Caldwell G; McCaffery J; Rochet J-C; Lindquist S, 2010, 'Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson's disease models', Disease Models and Mechanisms, 3, pp. 194-208

Journal articles | 2009

Bunce M; Worthy T; Phillips M; Holdaway RN; Willerslev E; Haile J; Shapiro RP; Scofield RP; Drummond A; Kamp PJJ; Cooper A, 2009, 'The evolutionary history of the extinct ratite moa and New Zealand Neogene paleogeography.', Proceedings of the National Academy of Sciences of the United States of America, 106, pp. 20646 - 20651

Journal articles | 2009

Gitler A; Chesi A; Geddie M; Strathearn K; Hamamichi S; Caldwell K; Hill KJ; Caldwell G; Cooper A; Rochet J; Lindquist S, 2009, 'Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity', Nature Genetics, 41, pp. 308 - 315

Journal articles | 2009

Gitler AD; Chesi A; Geddie ML; Strathearn KE; Hamamichi S; Hill KJ; Caldwell KA; Caldwell GA; Cooper AA; Rochet JC; Lindquist S, 2009, 'α-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity', Nature Genetics, 41, pp. 308 - 315, http://dx.doi.org/10.1038/ng.300

Journal articles | 2009

Zhao JT; Hill A; Varghese A; Cooper A; Swan H; Laitinen-Forsblom P; Rees M; Skinner J; Campbell TJ; Vandenberg JI, 2009, 'Not all hERG pore domain mutations have a severe phenotype: G584S has an inactivation gating defect with mild phenotype compared to G572S, which has a dominant negative trafficking defect and a severe phenotype', Journal of Cardiovascular Electrophysiology, 20, pp. 923 - 930, http://dx.doi.org/10.1111/j.1540-8167.2009.01468.x

Journal articles | 2008

Jackson CJ; Cooper A; Smillie L, 2008, 'A trait conceptualization of reward-reactivity: psychometric properties of the appetitive motivation scale (AMS)', Journal of Individual Differences, 29, pp. 168 - 180

Journal articles | 2007

Kincaid M; Cooper A, 2007, 'ERADicate ER stress or die trying', Antioxidants and Redox Signaling, 9, pp. 2373 - 2387

Journal articles | 2007

Kincaid M; Cooper A, 2007, 'Misfolded proteins traffic from the endoplasmic reticulum (ER) due to ER export signals', Molecular Biology of the Cell, 18, pp. 455 - 463

Journal articles | 2006

Cooper AA; Gitler AD; Cashikar A; Haynes CM; Hill KJ; Bhullar B; Liu K; Xu K; Strathearn KE; Liu F; Cao S; Caldwell KA; Caldwell GA; Marsischky G; Kolodner RD; LaBaer J; Rochet JC; Bonini NM; Lindquist S, 2006, 'α-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models', Science, 313, pp. 324 - 328, http://dx.doi.org/10.1126/science.1129462

Journal articles | 2006

Molero JC; Waring S; Cooper A; Turner N; Laybutt DR; Cooney GJ; James DE, 2006, 'Casitas b-lineage lymphoma-deficient mice are protected against high-fat died-induced obesity and insulin resistance', Diabetes, 55, pp. 708 - 715

Journal articles | 2004

Haynes CM; Titus EA; Cooper AA, 2004, 'Degradation of misfolded proteins prevents ER-derived oxidative stress and cell death', Molecular Cell, 15, pp. 767 - 776, http://dx.doi.org/10.1016/j.molcel.2004.08.025

Journal articles | 2002

Haynes CM; Caldwell S; Cooper AA, 2002, 'An HRD/DER-independent er quality control mechanism involves Rsp5p-dependent ubiquitination and ER-Golgi transport', Journal of Cell Biology, 158, pp. 91 - 101, http://dx.doi.org/10.1083/jcb.200201053

Journal articles | 2001

Caldwell SR; Hill KJ; Cooper AA, 2001, 'Degradation of Endoplasmic Reticulum (ER) Quality Control Substrates Requires Transport between the ER and Golgi', Journal of Biological Chemistry, 276, pp. 23296 - 23303, http://dx.doi.org/10.1074/jbc.M102962200

Journal articles | 2000

Hill K; Cooper AA, 2000, 'Degradation of unassembled Vph1p reveals novel aspects of the yeast ER quality control system', EMBO Journal, 19, pp. 550 - 561, http://dx.doi.org/10.1093/emboj/19.4.550

Journal articles | 1996

Cooper AA; Stevens TH, 1996, 'Vps10p cycles between the late-Golgi and prevacuolar compartments in its function as the sorting receptor for multiple yeast vacuolar hydrolases', Journal of Cell Biology, 133, pp. 529 - 541, http://dx.doi.org/10.1083/jcb.133.3.529

Journal articles | 1995

Cooper AA; Stevens TH, 1995, 'Protein splicing: self-splicing of genetically mobile elements at the protein level', Trends in Biochemical Sciences, 20, pp. 351 - 356, http://dx.doi.org/10.1016/S0968-0004(00)89075-1

Journal articles | 1995

Piper RC; Cooper AA; Yang H; Stevens TH, 1995, 'VPS27 controls vacuolar and endocytic traffic through a prevacuolar compartment in Saccharomyces cerevisiae', Journal of Cell Biology, 131, pp. 603 - 617, http://dx.doi.org/10.1083/jcb.131.3.603

Journal articles | 1993

Cooper AA; Chen YJ; Lindorfer MA; Stevens TH, 1993, 'Protein splicing of the yeast TFP1 intervening protein sequence: A model for self-excision', EMBO Journal, 12, pp. 2575 - 2583

Journal articles | 1993

Cooper AA; Stevens TMH, 1993, 'Protein splicing: Excision of intervening sequences at the protein level', BioEssays, 15, pp. 667 - 674, http://dx.doi.org/10.1002/bies.950151006

Journal articles | 1992

Cooper A; Bussey H, 1992, 'Yeast Kex1p is a Golgi-associated membrane protein: Deletions in a cytoplasmic targeting domain result in mislocalization to the vacuolar membrane', Journal of Cell Biology, 119, pp. 1459 - 1468

Journal articles | 1990

Thomas L; Cooper A; Bussey H; Thomas G, 1990, 'Yeast KEX1 protease cleaves a prohormone processing intermediate in mammalian cells', Journal of Biological Chemistry, 265, pp. 10821 - 10824

Journal articles | 1989

Cooper A; Bussey H, 1989, 'Characterization of the yeast KEX1 gene product: a carboxypeptidase involved in processing secreted precursor proteins.', Molecular and cellular biology, 9, pp. 2706 - 2714, http://dx.doi.org/10.1128/MCB.9.6.2706

Journal articles | 1965

Barclay GA; Cooper A, 1965, '685. The crystal structure of copper(II) ethyl acetoacetate', Journal of the Chemical Society (Resumed), pp. 3746 - 3751, http://dx.doi.org/10.1039/JR9650003746
Preprints | 2024

Nazeen S; Wang X; Zielinski D; Lam I; Hallacli E; Xu P; Ethier E; Strom R; Zanella CA; Nithianandam V; Ritter D; Henderson A; Saurat N; Afroz J; Nutter-Upham A; Benyamini H; Copty J; Ravishankar S; Morrow A; Mitchel J; Neavin D; Gupta R; Farbehi N; Grundman J; Myers RH; Scherzer CR; Trojanowski JQ; Van Deerlin VM; Cooper AA; Lee EB; Erlich Y; Lindquist S; Peng J; Geschwind DH; Powell J; Studer L; Feany MB; Sunyaev SR; Khurana V, 2024, Deep sequencing of proteotoxicity modifier genes uncovers a Presenilin-2/beta-amyloid-actin genetic risk module shared among alpha-synucleinopathies., http://dx.doi.org/10.1101/2024.03.03.583145

Preprints | 2023

Farrow S; Gokuladhas S; Schierding W; Pudjihartono M; Perry J; Cooper A; O'Sullivan J, 2023, Fine-mapping identifies 27 allele-specific MPRA regulatory variants in Parkinson’s disease related loci, http://dx.doi.org/10.21203/rs.3.rs-3371418/v1

Preprints | 2023

O'Sullivan J; Gokuladhas S; Fadason T; Farrow S; Cooper A, 2023, Identifying the genetic links between Parkinson’s disease and non-motor symptoms: novel insights into disease mechanisms, http://dx.doi.org/10.21203/rs.3.rs-3177049/v1

Preprints | 2021

Farrow S; Schierding W; Gokuladhas S; Golovina E; Fadason T; Cooper A; O’Sullivan J, 2021, Establishing gene regulatory networks from Parkinson’s disease risk loci, http://dx.doi.org/10.1101/2021.04.08.439080

Preprints | 2021

Ho D; Schierding W; Farrow S; Cooper A; Kempa-Liehr A; O’Sullivan J, 2021, Machine learning identifies six genetic variants and alterations in the Heart Atrial Appendage as key contributors to PD risk predictivity, http://dx.doi.org/10.1101/2021.06.29.21259734

Preprints | 2021

Lau D; Magnan C; Hill K; Cooper A; Gambin Y; Sierecki E, 2021, Single molecule fingerprinting reveals different amplification properties of α-synuclein oligomers and preformed fibrils in seeding assay, http://dx.doi.org/10.1101/2021.08.09.455607

Preprints | 2020

Fadason T; Gokuladhas S; Golovina E; Ho D; Farrow S; Nyaga D; Pan H; Karnani N; Wong C; Cooper A; Schierding W; O’Sullivan JM, 2020, A transcription regulatory network within the ACE2 locus may promote a pro-viral environment for SARS-CoV-2 by modulating expression of host factors, http://dx.doi.org/10.1101/2020.04.14.042002

Reports | 2019

Dong X; Liao Z; Gritsch D; Hadzhiev Y; Bai Y; Locascio JJ; Guennewig B; Liu G; Blauwendraat C; Wang T; Adler CH; Hedreen JC; Faull RLM; Frosch MP; Nelson PT; Rizzu P; Cooper AA; Heutink P; Beach TG; Mattick JS; Müller F; Scherzer CR, 2019, Erratum to: Enhancers active in dopamine neurons are a primary link between genetic variation and neuropsychiatric disease (Nature Neuroscience, (2018), 21, 10, (1482-1492), 10.1038/s41593-018-0223-0), http://dx.doi.org/10.1038/s41593-018-0277-z

Preprints | 2017

Guennewig B; Davies Z; Pinese M; Cooper AA, 2017, blkbox: Integration of multiple machine learning approaches to identify disease biomarkers, http://dx.doi.org/10.1101/123430

Follow

Dr Antony Cooper